Risk of Infections and Mortality in Danish Patients with Cancer Diagnosed with Bone Metastases: a Population-based Cohort Study

Overview

Journal BMJ Open

Specialty General Medicine

Date 2021 Dec 2

PMID 34853103

Citations 3

Authors

Thomas Johannesson Hjelholt

Thomas Bojer Rasmussen

Anouchka Seesaghur

Rohini K Hernandez

Andrea Marongiu

Niels Obel

Henrik Toft Sorensen

A B Pedersen

Affiliations

Soon will be listed here.

Abstract

Objectives: Risk of infections in patients with solid cancers and bone metastases (BM) and the subsequent impact on prognosis is unclear. We examined the risk of infections among patients with cancer diagnosed with BM and the subsequent impact of infections on mortality.

Design: Population-based cohort study.

Setting: Danish medical databases holding information on all hospital contacts in Denmark.

Participants: Adult patients with solid cancers and BM between 1 January 1994 and 30 November 2013.

Outcome Measures: In the risk analyses, the outcome was time to hospitalisation for common severe infections, pneumonia, sepsis and urinary tract infections. In the mortality analysis, we used Cox regression to compute HRs of death, modelling infection as time-varying exposure, stratifying for primary cancer type and adjusting for age, sex and comorbidities.

Results: Among 23 336 patients with cancer and BM, cumulative incidences of common severe infections were 4.6%, 14.0% and 20.0% during 1 month, 1 year and 10 years follow-up. The highest incidence was observed for pneumonia, followed by urinary tract infections and sepsis. Infection was a strong predictor of 1 month mortality (adjusted HR: 2.1 (95% CI 1.8 to 2.3)) and HRs increased after 1 and 10 years: 2.4 (95% CI 2.3 to 2.6) and 2.4 (95% CI 2.4 to 2.6). Sepsis and pneumonia were the strongest predictors of death. Results were consistent across cancer types.

Conclusion: Patients with cancer and BM were at high risk of infections, which was associated with a more than twofold increased risk of death for up to 10 years of follow-up. The findings underscore the importance of preventing infections in patients with cancer and BM.

Citing Articles

Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.

Seesaghur A, Egger P, Warden J, Abbasi A, Levick B, Riaz M BMJ Open. 2023; 13(5):e069214.

PMID: 37156580 PMC: 10410833. DOI: 10.1136/bmjopen-2022-069214.

Nanopore-based metagenomic sequencing for the rapid and precise detection of pathogens among immunocompromised cancer patients with suspected infections.

Deng Q, Cao Y, Wan X, Wang B, Sun A, Wang H Front Cell Infect Microbiol. 2022; 12:943859.

PMID: 36204638 PMC: 9530710. DOI: 10.3389/fcimb.2022.943859.

Antibiotic Therapy in Integrated Oncology and Palliative Cancer Care: An Observational Study.

Moen M, Lohre E, Jakobsen G, Thronaes M, Klepstad P Cancers (Basel). 2022; 14(7).

PMID: 35406374 PMC: 8996984. DOI: 10.3390/cancers14071602.

References

Deyo R, Cherkin D, Ciol M . Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45(6):613-9. DOI: 10.1016/0895-4356(92)90133-8. View

Carlin B, Andriole G . The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma. Cancer. 2000; 88(12 Suppl):2989-94. DOI: 10.1002/1097-0142(20000615)88:12+<2989::aid-cncr14>3.3.co;2-h. View

Thygesen S, Christiansen C, Christensen S, Lash T, Sorensen H . The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011; 11:83. PMC: 3125388. DOI: 10.1186/1471-2288-11-83. View

Benchimol E, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I . The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015; 12(10):e1001885. PMC: 4595218. DOI: 10.1371/journal.pmed.1001885. View

Gudiol C, Aguado J, Carratala J . Bloodstream infections in patients with solid tumors. Virulence. 2016; 7(3):298-308. PMC: 4871686. DOI: 10.1080/21505594.2016.1141161. View

Coleman R . Skeletal complications of malignancy. Cancer. 1997; 80(8 Suppl):1588-94. DOI: 10.1002/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.3.co;2-z. View

Garcia-Vidal C, Ardanuy C, Gudiol C, Cuervo G, Calatayud L, Bodro M . Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in cancer patients. J Infect. 2012; 65(6):521-7. DOI: 10.1016/j.jinf.2012.08.015. View

Bos M, Smeets L, Dumay I, de Jonge E . Bloodstream infections in patients with or without cancer in a large community hospital. Infection. 2013; 41(5):949-58. DOI: 10.1007/s15010-013-0468-1. View

de Groot V, Beckerman H, Lankhorst G, Bouter L . How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003; 56(3):221-9. DOI: 10.1016/s0895-4356(02)00585-1. View

10.

Viadana E, Cotter R, PICKREN J, Bross I . An autopsy study of metastatic sites of breast cancer. Cancer Res. 1973; 33(1):179-81. View

11.

Tumbarello M, Spanu T, Caira M, Trecarichi E, Laurenti L, Montuori E . Factors associated with mortality in bacteremic patients with hematologic malignancies. Diagn Microbiol Infect Dis. 2009; 64(3):320-6. DOI: 10.1016/j.diagmicrobio.2009.02.008. View

12.

Storm H, Michelsen E, Clemmensen I, Pihl J . The Danish Cancer Registry--history, content, quality and use. Dan Med Bull. 1997; 44(5):535-9. View

13.

Norgaard M, Jensen A, Jacobsen J, Cetin K, Fryzek J, Sorensen H . Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). J Urol. 2010; 184(1):162-7. DOI: 10.1016/j.juro.2010.03.034. View

14.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007; 4(10):e296. PMC: 2020495. DOI: 10.1371/journal.pmed.0040296. View

15.

Storm H . Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol. 1988; 17(1):44-9. DOI: 10.1093/ije/17.1.44. View

16.

Viadana E, Bross I, PICKREN J . An autopsy study of some routes of dissemination of cancer of the breast. Br J Cancer. 1973; 27(4):336-40. PMC: 2008793. DOI: 10.1038/bjc.1973.40. View

17.

Lyman G, Yau L, Nakov R, Krendyukov A . Overall survival and risk of second malignancies with cancer chemotherapy and G-CSF support. Ann Oncol. 2018; 29(9):1903-1910. DOI: 10.1093/annonc/mdy311. View

18.

Williams M, Braun L, Cooper L, Johnston J, Weiss R, Qualy R . Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care. 2004; 8(5):R291-8. PMC: 1065011. DOI: 10.1186/cc2893. View

19.

Cetin K, Christiansen C, Jacobsen J, Norgaard M, Sorensen H . Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study. Lung Cancer. 2014; 86(2):247-54. DOI: 10.1016/j.lungcan.2014.08.022. View

20.

Wilchesky M, Tamblyn R, Huang A . Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004; 57(2):131-41. DOI: 10.1016/S0895-4356(03)00246-4. View